Alessio Ciulli studied chemistry in Florence, Italy, and obtained his PhD from the University of Cambridge, UK, in 2006. After postdoctoral research in Cambridge and a brief visit at Yale University in the USA, he returned to Cambridge in 2009 to start his independent laboratory. In 2013, he moved to the University of Dundee, UK, where he was promoted to full professor in 2016. He has received numerous awards, including most recently the Prous Institute – Overton and Meyer Award for New Technologies in Drug Discovery. He is the scientific founder of Amphista therapeutics, a targeted protein degradation company spin out of his laboratory, and the founder of the University of Dundee’s new Centre for Targeted Protein Degradation which he directs and opened in January 2023.